417 related articles for article (PubMed ID: 19946469)
1. Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53.
Heminger K; Markey M; Mpagi M; Berberich SJ
Aging (Albany NY); 2009 Jan; 1(1):89-108. PubMed ID: 19946469
[TBL] [Abstract][Full Text] [Related]
2. HDMX-L is expressed from a functional p53-responsive promoter in the first intron of the HDMX gene and participates in an autoregulatory feedback loop to control p53 activity.
Phillips A; Teunisse A; Lam S; Lodder K; Darley M; Emaduddin M; Wolf A; Richter J; de Lange J; Verlaan-de Vries M; Lenos K; Böhnke A; Bartel F; Blaydes JP; Jochemsen AG
J Biol Chem; 2010 Sep; 285(38):29111-27. PubMed ID: 20659896
[TBL] [Abstract][Full Text] [Related]
3. Levels of HdmX expression dictate the sensitivity of normal and transformed cells to Nutlin-3.
Patton JT; Mayo LD; Singhi AD; Gudkov AV; Stark GR; Jackson MW
Cancer Res; 2006 Mar; 66(6):3169-76. PubMed ID: 16540668
[TBL] [Abstract][Full Text] [Related]
4. HdmX overexpression inhibits oncogene induced cellular senescence.
Miller KR; Kelley K; Tuttle R; Berberich SJ
Cell Cycle; 2010 Aug; 9(16):3376-82. PubMed ID: 20724842
[TBL] [Abstract][Full Text] [Related]
5. HdmX stimulates Hdm2-mediated ubiquitination and degradation of p53.
Linares LK; Hengstermann A; Ciechanover A; Müller S; Scheffner M
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12009-14. PubMed ID: 14507994
[TBL] [Abstract][Full Text] [Related]
6. HDM2 and HDMX Proteins in Human Cancer.
Hároníková L; Vojtěšek B
Klin Onkol; 2018; 31(Suppl 2):63-70. PubMed ID: 31023026
[TBL] [Abstract][Full Text] [Related]
7. RNAi knockdown of HdmX or Hdm2 leads to new insights into p53 signaling.
Berberich SJ
Cell Cycle; 2010 Sep; 9(18):3640-1. PubMed ID: 20855947
[No Abstract] [Full Text] [Related]
8. Abrogation of Wip1 expression by RITA-activated p53 potentiates apoptosis induction via activation of ATM and inhibition of HdmX.
Spinnler C; Hedström E; Li H; de Lange J; Nikulenkov F; Teunisse AF; Verlaan-de Vries M; Grinkevich V; Jochemsen AG; Selivanova G
Cell Death Differ; 2011 Nov; 18(11):1736-45. PubMed ID: 21546907
[TBL] [Abstract][Full Text] [Related]
9. c-Abl phosphorylates Hdmx and regulates its interaction with p53.
Zuckerman V; Lenos K; Popowicz GM; Silberman I; Grossman T; Marine JC; Holak TA; Jochemsen AG; Haupt Y
J Biol Chem; 2009 Feb; 284(6):4031-9. PubMed ID: 19075013
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation.
Wang YV; Wade M; Wong E; Li YC; Rodewald LW; Wahl GM
Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12365-70. PubMed ID: 17640893
[TBL] [Abstract][Full Text] [Related]
11. Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization.
Giglio S; Mancini F; Gentiletti F; Sparaco G; Felicioni L; Barassi F; Martella C; Prodosmo A; Iacovelli S; Buttitta F; Farsetti A; Soddu S; Marchetti A; Sacchi A; Pontecorvi A; Moretti F
Cancer Res; 2005 Nov; 65(21):9687-94. PubMed ID: 16266988
[TBL] [Abstract][Full Text] [Related]
12. Identification of a Structural Determinant for Selective Targeting of HDMX.
Ben-Nun Y; Seo HS; Harvey EP; Hauseman ZJ; Wales TE; Newman CE; Cathcart AM; Engen JR; Dhe-Paganon S; Walensky LD
Structure; 2020 Jul; 28(7):847-857.e5. PubMed ID: 32359398
[TBL] [Abstract][Full Text] [Related]
13. Functional profiling of p53-binding sites in Hdm2 and Hdmx using a genetic selection system.
Datta S; Bucks ME; Koley D; Lim PX; Savinov SN
Bioorg Med Chem; 2010 Aug; 18(16):6099-108. PubMed ID: 20638853
[TBL] [Abstract][Full Text] [Related]
14. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.
Meulmeester E; Maurice MM; Boutell C; Teunisse AF; Ovaa H; Abraham TE; Dirks RW; Jochemsen AG
Mol Cell; 2005 May; 18(5):565-76. PubMed ID: 15916963
[TBL] [Abstract][Full Text] [Related]
15. Understanding the interaction of 14-3-3 proteins with hDMX and hDM2: a structural and biophysical study.
Srdanović S; Wolter M; Trinh CH; Ottmann C; Warriner SL; Wilson AJ
FEBS J; 2022 Sep; 289(17):5341-5358. PubMed ID: 35286747
[TBL] [Abstract][Full Text] [Related]
16. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
Lau LM; Nugent JK; Zhao X; Irwin MS
Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
[TBL] [Abstract][Full Text] [Related]
17. Hdmx modulates the outcome of p53 activation in human tumor cells.
Wade M; Wong ET; Tang M; Stommel JM; Wahl GM
J Biol Chem; 2006 Nov; 281(44):33036-44. PubMed ID: 16905769
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.
Swetzig WM; Wang J; Das GM
Oncotarget; 2016 Mar; 7(13):16049-69. PubMed ID: 26909605
[TBL] [Abstract][Full Text] [Related]
19. Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation.
Migliorini D; Danovi D; Colombo E; Carbone R; Pelicci PG; Marine JC
J Biol Chem; 2002 Mar; 277(9):7318-23. PubMed ID: 11744695
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Small Molecule That Overcomes HdmX-Mediated Suppression of p53.
Karan G; Wang H; Chakrabarti A; Karan S; Liu Z; Xia Z; Gundluru M; Moreton S; Saunthararajah Y; Jackson MW; Agarwal MK; Wald DN
Mol Cancer Ther; 2016 Apr; 15(4):574-582. PubMed ID: 26883273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
